Karyopharm reports business highlights and second quarter 2021 financial results

Newton, mass., aug. 5, 2021 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq:kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported business highlights and financial results for the quarter ended june 30, 2021.

KPTI Ratings Summary

KPTI Quant Ranking